News — WASHINGTON — Discrimination experienced by Black people can affect their health and increase their frailty, which can be particularly impactful for cancer survivors, according to a new study by researchers at and colleagues at the in Detroit. The researchers assessed frailty by a number of factors, including whether a participant had several chronic diseases, poor muscle strength and difficulty performing activities of daily living.
The findings appeared March 20, 2023, in Cancer.
“Discrimination can act as a chronic stressor which can throw the body off balance, resulting in increases in blood pressure, heart rate, metabolism, inflammation, and numerous other factors. These stressors can also increase rates of aging, leading to greater risk of frailty,” says the study’s lead investigator, , director of the . “We hypothesize that discrimination can lead to an older biological age than a person’s actual chronological age. This is important to understand as there have been virtually no studies of the relationships between discrimination and aging in the setting of cancer survivorship.”
The investigators looked at associations between discrimination and frailty among 2,232 Black breast, lung, prostate and colorectal cancer survivors who were within five years of their diagnoses and were no longer actively being treated for their cancers. Survivors were 62 years of age on average (with ages ranging from 23 to 84) at the time of the study, but they may have experienced discrimination over many decades of their lives. All participants were part of the (ROCS), which is the largest U.S. study of Black cancer survivors.
The researchers surveyed the participants, via phone, in writing, or online about any aging-related diseases they had, their ability to maintain a healthy lifestyle, and most importantly, about major discrimination events they may have experienced over their lifetimes, specifically targeting seven areas:
- being unfairly fired or denied a promotion in their job;
- not being hired for a job;
- being unfairly stopped, searched, questioned, physically threatened or abused by police officers;
- being unfairly discouraged by a teacher or advisor from continuing their education;
- unfairly receiving worse medical care than other people;
- being prevented from moving into a neighborhood because a landlord or realtor refused to sell or rent them a house or an apartment; and/or
- moved into a neighborhood where neighbors made life difficult.
Based on the survey results, the majority of cancer survivors were classified as either prefrail (42.7%), meaning they had some health difficulties, or frail (32.9%). Only 24.4% of those surveyed had few or no signs of frailty. When queried about the seven discrimination areas, 63.2% of the participants reported experiencing major discrimination, with an average respondent reporting 2.4 types of discrimination.
“For those cancer survivors who reported four to seven types of discrimination events, we observed a large, clinically meaningful increase in frailty scores compared to survivors with fewer discrimination events,” explains Mandelblatt, also a professor of oncology and medicine at the Georgetown University School of Medicine. “Significantly, this pattern of discrimination affecting frailty was consistent across the four types of cancer surveyed, indicating that discrimination is an important factor to study and understand in Black cancer survivors in order to improve their quality and length of life.”
“Our results indicate that after considering the effects of traditional factors on poor health, such as income, education and types of cancer treatment, discrimination was a significant factor explaining frailty and it acted independently of the other variables,” says , co-lead author on the paper and co-principal investigator of the Detroit ROCS. “Regardless of whether you were rich or poor, if you experienced more discrimination then you had greater frailty.” Schwartz is also professor and associate chair of oncology at Wayne State University School of Medicine, and deputy center director and executive vice president for research and academic affairs at Karmanos.
For their next steps, the researchers are hoping to study the relationships between major discrimination, other chronic life stressors and markers of biological aging and test how cancer and its treatment further contributes to biological aging among racial and ethnic minorities.
“We have long since recognized the impact of discrimination on health and well-being in Black communities,” says study co-author , a professor of oncology and associate director for at Georgetown Lombardi. “We hope that this study leads to more discussions between providers and their patients about the types of discrimination they have experienced and gives providers a greater understanding of how discrimination impacts frailty.”
###
Additional authors include Xingtao Zhou and Traci Bethea at Georgetown Lombardi; Julie Ruterbusch, Hayley Thompson and Kristen Purrington at Wayne State University School of Medicine and Karmanos Cancer Institute.
The authors report having no personal financial interests related to the study.
This research was supported by National Cancer Institute grants U01 CA199240, R01CA129769, R35CA197289 and K01CA212056 and a National Institute on Aging grant R21AG07500. This work was supported by the Epidemiology Research Core and the National Cancer Institute Center Grant (P30CA022453) awarded to the Karmanos Cancer Institute at Wayne State University.
About Georgetown University’s Lombardi Comprehensive Cancer Center
Georgetown’s Lombardi Comprehensive Cancer Center is designated by the National Cancer Institute (NCI) as a comprehensive cancer center. A part of Georgetown University Medical Center, Georgetown Lombardi is the only comprehensive cancer center in the Washington D.C. area. It serves as the research engine for MedStar Health, Georgetown University’s clinical partner. Georgetown Lombardi is also an NCI recognized consortium with John Theurer Cancer Center/Hackensack Meridian Health in Bergen County, New Jersey. The consortium reflects an integrated cancer research enterprise with scientists and physician-researchers from both locations. Georgetown Lombardi seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic, translational and clinical research, patient care, community education and outreach to service communities throughout the Washington region, while its consortium member John Theurer Cancer Center/Hackensack Meridian Health serves communities in northern New Jersey. Georgetown Lombardi is a member of the NCI Community Oncology Research Program (UG1CA239758). Georgetown Lombardi is supported in part by a National Cancer Institute Cancer Center Support Grant (P30CA051008). Connect with Georgetown Lombardi on Facebook (Facebook.com/GeorgetownLombardi) and Twitter (@LombardiCancer).
RSS